Home » Stocks » JAZZ

Jazz Pharmaceuticals PLC (JAZZ)

Stock Price: $168.09 USD 0.93 (0.56%)
Updated Apr 20, 2021 4:00 PM EDT - Market closed
Market Cap 9.40B
Revenue (ttm) 2.36B
Net Income (ttm) 238.62M
Shares Out 56.33M
EPS (ttm) 4.22
PE Ratio 39.83
Forward PE 10.60
Dividend n/a
Dividend Yield n/a
Trading Day April 20
Last Price $168.09
Previous Close $167.16
Change ($) 0.93
Change (%) 0.56%
Day's Open 165.41
Day's Range 164.01 - 168.40
Day's Volume 561,981
52-Week Range 101.81 - 178.64

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

DUBLIN, April 20, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) (the "Company") announced today that its wholly owned subsidiary, Jazz Securities Designated Activity Company (the "Issuer"...

13 hours ago - PRNewsWire

DUBLIN, April 20, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced positive results from the Phase 3 study of XywavTM (calcium, magnesium, potassium, and sodium oxybates) ora...

14 hours ago - PRNewsWire

DUBLIN, April 19, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2021 first quarter financial results on Tuesday, May 4, 2021 after the close of the...

1 day ago - PRNewsWire

Shares of cannabis-related stocks and ETFs continue to be in good shape after a solid run last year.

Other stocks mentioned: CNBS, MJ, MSOS, POTX, THCX, TOKE, YOLO
6 days ago - Zacks Investment Research

JAZZ focuses on expanding label of its recently approved sleep drug, Xywav - a low sodium-formulation of Xyrem.

1 week ago - Zacks Investment Research

DUBLIN, April 12, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review designation and confirmed the ...

1 week ago - PRNewsWire

2020 was a big year for the cannabis industry, but 2021 is shaping up to be even bigger.

Other stocks mentioned: GRWG, GTBIF, GWPH
1 week ago - The Motley Fool

Although research on the medical benefits of the drug is limited in the U.S., we have some ideas about marijuana's ability to disrupt the healthcare industry.

Other stocks mentioned: GWPH
1 week ago - The Motley Fool

Could these areas see more gains ahead?

Other stocks mentioned: APHA, BTI, FRO, GWPH, MJ, NAT, OGI ...
1 week ago - The Motley Fool

With the trading day approaching halfway over, the broad markets were trading marginally positive.

Other stocks mentioned: ANF, PFE, TEVA, DHR, FLXN
1 week ago - 24/7 Wall Street

Cannabinoid-based medicines have made major advancements in research and uptake over the past few years.

Other stocks mentioned: GWPH
2 weeks ago - The Motley Fool

Jazz Pharmaceuticals (JAZZ) gets FDA approval for label expansion of its cancer drug, Vyxeos, in pediatric patients with newly-diagnosed therapy-related acute myeloid leukemia.

2 weeks ago - Zacks Investment Research

DUBLIN, March 30, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) approved a revised label for Vyxeos® (daunorubicin and cyt...

3 weeks ago - PRNewsWire

Jazz (JAZZ) reported earnings 30 days ago. What's next for the stock?

3 weeks ago - Zacks Investment Research

Multiple high-profile companies may still be on the hunt for a deal.

Other stocks mentioned: ACB, APHA, BTI, GWPH, OGI, SNDL, TLRY
3 weeks ago - The Motley Fool

BZUN, EQR, FRPT, JAZZ, and SPTN have been added to the Zacks Rank #5 (Strong Sell) List on March 23, 2021

Other stocks mentioned: BZUN, EQR, FRPT, SPTN
4 weeks ago - Zacks Investment Research

DUBLIN, March 22, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will webcast its corporate presentation at the 10th Annual J.P. Morgan Napa Valley Forum.

4 weeks ago - PRNewsWire

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

Other stocks mentioned: AMPH, KNBWY, NSRGY, TSCDY
1 month ago - Zacks Investment Research

DUBLIN, March 18, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and the Hypersomnia Foundation today announced the launch of I Have IH, a disease awareness campaign that aims to increase ...

1 month ago - PRNewsWire

But the low prices may not last for long, because these companies' futures look bright.

Other stocks mentioned: ABBV, HPE
1 month ago - The Motley Fool

These are the top players in the expanding $19.6 billion U.S. marijuana market.

Other stocks mentioned: GWPH, JUSHF
1 month ago - The Motley Fool

After soaring to all-time highs last month, exchange traded funds tracking cannabis stocks are coming back down to test a key support line. The post Don't Miss These 2 Ways To Play The Hot Marijuana Sto...

Other stocks mentioned: APHA, CGC, GWPH, IIPR, POTX, TLRY, VFF ...
1 month ago - Investors Business Daily

Each of these cannabis stocks blazed higher by between 20% and 208% last month.

Other stocks mentioned: APHA, CURLF, GWPH, MMNFF, OGI, SNDL, TLRY
1 month ago - The Motley Fool

Welcome back to our weekly series, Sc haeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will cont...

Other stocks mentioned: APHA, ARNA, IIPR, SNDL, TLRY, VFF, YCBD
1 month ago - Schaeffers Research

Jazz Pharmaceuticals (JAZZ) reports mixed fourth-quarter 2020 results as earnings miss estimates while sales beat the same. Shares down.

1 month ago - Zacks Investment Research

The company beat top-line estimates, but missed on the bottom line.

1 month ago - The Motley Fool

Shares of Jazz Pharmaceuticals (NASDAQ:JAZZ) were flat in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 9.50% year over year to $4.00, which ...

1 month ago - Benzinga

DUBLIN, Feb. 23, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will webcast its corporate presentation at the Cowen 41st Annual Healthcare conference. Bru...

1 month ago - PRNewsWire

With many people seeking natural therapies to address pandemic-related stress, the backdrop is favorable for marijuana stocks. The post 8 Medical Marijuana Stocks That Are Just What the Doctor Ordered a...

Other stocks mentioned: CRLBF, CRON, GRWG, GTBIF, IIPR, TCNNF, TLRY
1 month ago - InvestorPlace

Jazz Pharmaceuticals (NASDAQ:JAZZ) releases its next round of earnings this Tuesday, February 23. Here is Benzinga's essential guide to Jazz Pharmaceuticals's Q4 earnings report.

1 month ago - Benzinga

Let us take a look at five small biotech companies, JAZZ, ARNA, HALO, EPZM, ESPR, which are gearing up for their earnings release.

1 month ago - Zacks Investment Research

Increasingly, the Wall Street firms we cover are starting to agree that, while the future is still bright for the U.S.

Other stocks mentioned: CZR, DKNG, EXR
1 month ago - 24/7 Wall Street

CNBC's cannabis expert Tim Seymour discusses the outlook for the industry.

Other stocks mentioned: APHA, CGC, CNBS, GWPH, MJ, POTX, THCX ...
2 months ago - Zacks Investment Research

Jazz Pharmaceuticals PLC's (NASDAQ:JAZZ) recently-announced deal to acquire cannabis-derived drug maker GW Pharmaceuticals plc (NASDAQ:GWPH) for US$7.2 billion in cash and stock has boosted investor int...

Other stocks mentioned: GWPH, OILFF
2 months ago - Proactive Investors

DUBLIN, Feb. 16, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the completion of the rolling submission for the supplemental New Drug Application (sNDA) to the U.S. Food a...

2 months ago - PRNewsWire

The sector is hot again on the heels of two large deals.

Other stocks mentioned: ACB, ACRGF, APHA, CGC, CRON, CURLF, GWPH ...
2 months ago - The Motley Fool

Cannabis stocks seem poised to gain on hopes of removal of the federal ban on cannabis products under the new administration.

Other stocks mentioned: APHA, CGC, GWPH, OGI, TLRY
2 months ago - Zacks Investment Research

DUBLIN, Feb. 9, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2020 fourth quarter and full year financial results on Tuesday, February 23, 2021, af...

2 months ago - PRNewsWire

The unusual biotech could be a bitter pill for short sellers to swallow.

Other stocks mentioned: GILD, GME, JNJ, LGND, MRK, NVS, PFE
2 months ago - The Motley Fool

A blockbuster deal announced earlier this week could be a sign of a bright future for cannabidiol-oriented pharmaceutical companies. On Wednesday, cancer therapy developer Jazz Pharmaceuticals PLC (NASD...

Other stocks mentioned: GWPH
2 months ago - Proactive Investors

Jazz Pharmaceuticals PLC's (NASDAQ:JAZZ) recently-announced deal to acquire cannabis-derived drug maker GW Pharmaceuticals plc (NASDAQ:GWPH) for US$7.2 billion in cash and stock has boosted investor int...

Other stocks mentioned: GWPH
2 months ago - Proactive Investors

Jazz is paying $7.2 million to buy the maker of CBD-derived drug Epidiolex. Is it a smart deal?

Other stocks mentioned: GWPH
2 months ago - The Motley Fool

Welcome back to our weekly series, Sc haeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will deve...

Other stocks mentioned: ARNA, GNLN, GRWG, GWPH, OGI, SNDL, TLRY ...
2 months ago - Schaeffers Research

With the trading day about halfway over, the broad markets were trading sideways into the weekend.

Other stocks mentioned: BIIB, FTNT, KSS, PINS, ARWR, DECK, INFI ...
2 months ago - 24/7 Wall Street

This troubled biopharma is making a multi-billion dollar bet on the cannabis industry in hopes of a turnaround.

2 months ago - The Motley Fool

The deal to buy GW Pharmaceuticals creates a leader in neuroscience.

Other stocks mentioned: GWPH
2 months ago - The Motley Fool

In a quiet market, marijuana companies stood out.

Other stocks mentioned: ACB, APHA, CGC, CRON, GWPH, TLRY
2 months ago - The Motley Fool

GW Pharmaceuticals (GWPH) stock is soaring higher on Wednesday following news that Jazz Pharmaceuticals (JAZZ) is acquiring the company. The post GWPH Stock: 12 Things to Know About the GW Pharma-Jazz P...

Other stocks mentioned: GWPH
2 months ago - InvestorPlace

Marijuana stocks rallied as Jazz Pharmaceuticals said it would buy GW Pharma. GWPH stock jumped.

Other stocks mentioned: GWPH
2 months ago - Investors Business Daily

Jazz Pharmaceuticals Plc said on Wednesday it would buy GW Pharmaceuticals plc in a $7.2 billion cash-and-stock deal to bolster its neuroscience business by adding a cannabis-based epilepsy treatment.

Other stocks mentioned: GWPH
2 months ago - Reuters

About JAZZ

Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement disorders; and in oncology, including hematologic and solid tumors. Its lead marketed products include Xyrem, an oral solution for the treatment of cataplexy and excessive daytime sleepiness (EDS) in narc... [Read more...]

Industry
Biotechnology
IPO Date
Jun 1, 2007
Stock Exchange
NASDAQ
Ticker Symbol
JAZZ
Full Company Profile

Financial Performance

In 2020, JAZZ's revenue was $2.36 billion, an increase of 9.34% compared to the previous year's $2.16 billion. Earnings were $238.62 million, a decrease of -54.41%.

Financial Statements

Analyst Forecasts

According to 20 analysts, the average rating for JAZZ stock is "Buy." The 12-month stock price forecast is 202.53, which is an increase of 20.49% from the latest price.

Price Target
$202.53
(20.49% upside)
Analyst Consensus: Buy